Abstract
Duodenal and gastric ulcers, when associated with H. pylori infection, are most efficially treated by eradication of the causative agent6. Ulcers refractory to antisecretory drugs can also be healed by this strategy6 and ulcer reccurrences and ulcer complications are virtually prevented2. The antimicrobial therapy is cost effective, when compared with long-term antisecretory treatment, and, especially in childhood it may be preventive against final development of gastric adenocarcinoma and MALT lymphoma3,4. A triple therapy using two antibiotics (mostly a macrolide and an imidazole) in combination with a proton pump inhibitor or a bismuth salt, currently seems to be the most promising eradication treatment with success rates between 70 and 90 percent1,5,6.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goddard A, Logan R (1995), Eur. J. Gastroenterol. Hepatol 7, 1–3.
Labenz J, Börsch G (1994), Digestion 55, 19–23.
Logan RPH (1994), Lancet 344, 1078–1079.
Powell KU, Bell GD, Bolton GH et al. (1994), Q. J. Med. 87, 283–290.
Treiber G, Walker S, Klotz U (1994), Clin. Pharmacol. Ther. 1994, 55, 486–491.
Tytgat GNJ 6 (1994), Aliment. Pharmacol. Ther. 8, 359–368.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kist, M.J. (1996). Summary of Workshop. In: Newell, D.G., Ketley, J.M., Feldman, R.A. (eds) Campylobacters, Helicobacters, and Related Organisms. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9558-5_76
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9558-5_76
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9560-8
Online ISBN: 978-1-4757-9558-5
eBook Packages: Springer Book Archive